LipoLat-CS202

· Peregrine Ophthalmic

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LipoLat-CS202, covering 2020-12-14 to 2020-12-14. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Extension of LipoLat-CS202